Niprd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Niprd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Niprd Today - Breaking & Trending Today

Nigeria lacks capacity for COVID-19 vaccine trials, say experts


• Delay in deploying vaccines causes virus to mutate
• South Africa was smart to do clinical trials, Says Agwale
• 75% doses deployed in only 10 countries
• 130 countries yet to administer single dose
Unlike South Africa and some developed nations, Nigeria lacks the capacity to conduct clinical trials on COVID-19 vaccines.
Chairman, Expert Review Committee on COVID-19 and a consultant virologist, Prof. Oyewale Tomori, told The Guardian yesterday his committee and National Agency for Food and Drug Administration and Control (NAFDAC) could only test for safety and not efficacy of food and drugs to be used in the country.
x
Reacting to report that Nigeria was waiting to receive 16 million doses of same vaccines that South Africa had halted and the question on whether Nigeria could conduct clinical trials like S.A to ascertain the potency of vaccine before administering it, Tomori said the country had neither the ....

South Africa , United States , Abuja Federal Capital Territory , Tedros Adhanom Ghebreyesus , Simon Agwale , Karen Ducey , Lolu Ojo , National Institute For Pharmaceutical Research , National Agency For Food , Central Bank , Expert Review Committee , Drug Administration , Vaccine Manufacturing Task Team , Redeemer University , Getty Images , Oyewale Tomori , National Agency , National Institute , Pharmaceutical Research , Manufacturing Task Team , Medical Director , Merit Healthcare , High Level Finance Ministrie Meeting , Covid 19 Vaccine , Prof Oyewale Tomori , ஒன்றுபட்டது மாநிலங்களில் ,

COVID-19: Inadequate fund affects local vaccine research, says NIPRD


COVID-19: Inadequate fund affects local vaccine research, says NIPRD
Friday Olokor, Abuja
Nigeria has not been progressing rapidly in the local research effort towards developing vaccines to fight COVID-19 because of poor funding, the National Institute of Pharmaceutical Research and Development said on Monday.
While warning the Federal Government to exercise caution and weigh all options before purchasing any of the vaccines for fighting coronavirus, the organisation raised fears that medicine security threat level in Nigeria was still very high, adding that prioritisation of local products and funding for research would help conquer the threat.
The Director-General and Chief Executive Officer of NIPRD, Dr Obi Adigwe, who stated these during a press conference in Abuja, lamented that lack of adequate funding was robbing the agency of opportunity to showcase the potentials and capacity of its professionals. ....

Burkina Faso , Abuja Federal Capital Territory , Martins Emeje , Medicine Centre , National Institute Of Pharmaceutical Research , Friday Olokor , National Institute , Pharmaceutical Research , Federal Government , Chief Executive Officer , Niprimune Capsule , Gross Domestic Product , Covid 19 Vaccine , Latest Nigerian News , Nigeria News , Latest News , End Sars , Reform Sars , Lagos Protest , Protest Near Me , Protests Today , Protests In Nigeria , புர்கினா ஃபாஸொ , கூட்டாட்சியின் மூலதனம் பிரதேசம் , மருந்து மையம் , தேசிய நிறுவனம் ஆஃப் மருந்து ஆராய்ச்சி ,